Table TDI-21. Gender ratio by primary drug — ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2006 [see all tables in this series...]

Part (ii) Ratio of males to females among all clients entering outpatient treatment

Country		Opioids	Cocaine	Stimulants	Hypnotics and sedatives	Hallucinogens	Volatile substances	Cannabis	Other drugs	Base (known status)
Bulgaria	(1)	3.9						11.0		797
Czech Republic		2.9	0.0	1.6	2.1	0.0	6.4	3.5	1.0	2172
Denmark	(2)	3.3	4.2	2.0	1.5			3.9	2.9	4386
Germany		3.4	6.0	3.0	0.7	5.2	2.0	6.3	3.7	55134
Ireland	(3)	2.7	5.4	3.2	1.7	1.0	0.7	6.0	0.5	3920
Greece		5.7	4.9	2.4	3.5	1.0		5.3	2.0	2653
Spain	(4)	5.1	6.1	4.3	1.6	12.0	10.3	5.6	2.2	50423
France		3.6	4.0	3.7	1.6	4.3	3.5	6.4	2.7	27254
Italy	(5)	4.9	10.0	3.7	2.1	1.8		10.8	2.4	47823
Cyprus	(6)	7.6	5.3	11.0	0.0			7.4		360
Latvia										0
Luxembourg	(7)	2.5	2.5	3.0		0.0		4.0		286
Hungary		2.8	2.3	3.0	0.6	3.8	4.7	7.5	1.3	10463
Malta	(8)	4.7	7.3	2.2			1.0	8.1		692
Netherlands		4.9	5.4	3.2	1.0	1.4	8.0	4.4	1.0	9623
Austria	(9)	2.3	4.2	2.3	1.9		0.0	5.6		3165
Portugal	(10)									0
Slovakia		2.6	3.0	2.4	0.8		8.5	7.6		791
Finland		1.8	1.0	1.3	2.4			3.2	2.0	1441
Sweden		1.5	2.3	1.4	1.0	6.0	4.0	3.5	5.6	1859
United Kingdom		2.6	3.0	1.9	1.3	2.2	1.8	3.2	1.9	112134
Total		3.3	5.3	2.3	1.1	2.9	2.6	5.2	2.2	4
Total base		174055	58859	13996	6279	607	666	74939	5975	335380

Notes:

 (1) No female cases for other drugs; no cases for Volatile substances and hallucinogens. 

 (2) No female cases for hallucinogens. 

 (3) No female cases for hallucinogens. 

 (4) Data refer to 2004. 

 (5) No female cases for hallucinogens and volatile substances. 

 (6) No female cases for stimulants; no cases for Volatile substances and other drugs. 

 (7) No female cases for other drugs; no cases for Volatile substances and hallucinogens. 

 (8) No female cases for hypnotics and volatile substances; no cases for hallucinogens and other drugs. 

 (9) No female cases for hallucinogens and cocaine. 

 (10) No female cases for hallucinogens and volatile substances. 

 See also 'General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2007 — TDI — outpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)